Now livetag icon
What will define the 2026 holiday season? 🔎 See how shoppers are deciding. Download the report →banner icon
Voronoi

March 2026

Voronoi Market Share Analysis for March 2026

Voronoi
Year Founded2015
Employees51 - 200
Annual Revenue$1M - $2M
voronoi.io
Voronoi
Voronoi (including company regionals)
  • voronoi.io
    voronoi.io
See more website traffic and engagement information

Voronoi Revenue up to March 2026 is 1M - 2M

revenue generated by Voronoi top domains

Voronoi top domains revenue over 3 years

Revenue for Voronoi top domains


Total visits to Voronoi's top domains

Understand Voronoi market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Voronoi's top domains

Analyze Voronoi engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Voronoi's top domains

See how Voronoi keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.


Voronoi top competitors by domain

Looks like there’s not enough data here

No Data to Display

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.


Top technologies used by Voronoi

These are the website technologies, by industry, used by Voronoi top domains

Widget (5)

Twemoji

Twemoji

Audio Video Media (2)

YouTube

YouTube

Content Management System (2)

WordPress

WordPress

Email Services (2)

G Suite

G Suite

More Technologies

6

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Voronoi

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsORIC Pharmaceuticals, Inc. partners with VORONOI, Inc..ORIC Pharmaceuticals has entered into an exclusive license agreement with Voronoi for the development of ORIC-114, a selective inhibitor targeting EGFR and HER2 exon 20 insertion mutations.

See all Voronoi signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.